The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Hepatitis C and hepatocellular carcinoma
Abstract
Hepatitis C virus (HCV) infection is now recognized to be a major risk factor for hepatocellular carcinoma (HCC), evidenced by finding both antibody to HCV (anti-HCV) and HCV RNA in serum of a substantial proportion of patients with HCC around the world and by the progression of liver disease to cirrhosis and HCC in individual patients infected with HCV. There seems to be an incubation period of two to three decades on average in most cases of HCV-related HCC. HCV infection usually results in development of HCC via cirrhosis, although the possibility of direct carcinogenic effects of HCV is still under study. Possible additional risk factors include infection with HCV genotype 1b, alcohol consumption, and co-infection with the hepatitis B virus. Estimates of the development of HCC among patients with cirrhosis of all types range between 1% and 4% per year. Assuming that 20% of patients with chronic hepatitis C go on to develop cirrhosis over a 10- year period, between 1.9% and 6.7% of all patients with chronic hepatitis C can be expected to develop HCC over the first two decades of infection. Although tests are available to screen for early HCC, the results of treating these small tumors have been disappointing. Thus, it is imperative that cost-effective means be developed for screening and prevention of HCV-related HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Fattovich, G., Giustina, G., Degos, F., Tremolada, F., Diodati, G., Almasio, P., Nevens, F., Solinas, A., Mura, D., Brouwer, J., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024300 · Cited by 1,399
Kiyosawa, K., Sodeyama, T., Tanaka, E., Gibo, Y., Yoshizawa, K., Nakano, Y., Furuta, S., Akahane, Y., Nishioka, K., Purcell, R. H., et al. (1990) · Hepatology · doi:10.1002/hep.1840120409 · Cited by 1,217
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., & Koike, K. (1998) · Nature Medicine · doi:10.1038/2053 · Cited by 1,206
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H., Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K., & Otani, S. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91739-x · Cited by 857
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
Bruix, J., Calvet, X., Costa, J., Ventura, M., Bruguera, M., Castillo, R., María Barrera, J., Ercilla, G., María Sanchez-Tapias, J., Vall, M., et al. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91015-5 · Cited by 734
Shafritz, D. A., Shouval, D., Sherman, H. I., Hadziyannis, S. J., & Kew, M. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198110293051807 · Cited by 711
Muto, Y., Moriwaki, H., Ninomiya, M., Adachi, S., Saito, A., Takasaki, K. T., Tanaka, T., Tsurumi, K., Okuno, M., Tomita, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342402 · Cited by 668
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Del Ninno, E., Dioguardi, N., Kuo, G., Donato, M. F., Tommasini, M. A., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis
di Bisceglie, A. M., Goodman, Z. D., Ishak, K. G., Hoofnagle, J. H., Melpolder, J. J., & Alter, H. J. (1991) · Hepatology · doi:10.1002/hep.1840140603 · Cited by 539
Self-citationIncrease in primary liver cancer in the UK, 1979–94
Taylor-Robinson, S. D., Foster, G. R., Arora, S., Hargreaves, S., & Thomas, H. C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63789-0 · Cited by 506
Epidemiology of Hepatitis C in the West
Alter, M. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007259 · Cited by 477
Kasahara, A., Hayashi, N., Mochizuki, K., Takayanagi, M., Yoshioka, K., Kakumu, S., Iijima, A., Urushihara, A., Kiyosawa, K., Okuda, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270529 · Cited by 467
TREATMENT OF ALCOHOLISM WITH A SENSITISING DRUG
Martensen-Larsen, O. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91515-3 · Cited by 442
Ray, R. B., Lagging, L. M., Meyer, K., & Ray, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4438-4443.1996 · Cited by 403
Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein
&NA; (1994) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199412000-00009 · Cited by 356
Relation of Interferon Therapy and Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Imai, Y., Kawata, S., Tamura, S., Yabuuchi, I., Noda, S., Inada, M., Maeda, Y., Shirai, Y., Fukuzaki, T., Kaji, I., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-2-199807150-00005 · Cited by 338
THE EPIDEMIOLOGY OF VIRAL HEPATITIS IN THE UNITED STATES
Alter, M. J., & Mast, E. E. (1994) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00146-1 · Cited by 324
Muto, Y., Moriwaki, H., & Shiratori, Y. (1998) · Digestion · doi:10.1159/000051435 · Cited by 315
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., Coderc, E., Reboullet, P., & Beaugrand, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80468-4 · Cited by 296
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
Suppression of Apoptotic Cell Death by Hepatitis C Virus Core Protein
Ray, R. B., Meyer, K., & Ray, R. (1996) · Virology · doi:10.1006/viro.1996.0644 · Cited by 265
Hepatitis C-associated hepatocellular carcinoma
Hasan, F., Jeffers, L. J., De Medina, M., Reddy, R. K., Parker, T., Schiff, E. R., Houghton, M., Choo, Q., & Kuo, G. (1990) · Hepatology · doi:10.1002/hep.1840120323 · Cited by 235
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07236-5 · Cited by 230
Benvegnù, L. (1998) · Padua Research Archive (University of Padova) · Cited by 221
Borzio, M., Bruno, S., Roncalli, M., Colloredo Mels, G., Ramella, G., Borzio, F., Leandro, G., Servida, E., & Podda, M. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90455-7 · Cited by 218
Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
Tanaka, K., Hirohata, T., Koga, S., Sugimachi, K., Kanematsu, T., Ohryohji, F., Nawata, H., Ishibashi, H., Maeda, Y., & Kiyokawa, H. (1991) · PubMed · Cited by 197
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study
Silini, E., Bottelli, R., Asti, M., Bruno, S., Candusso, M., Brambilla, S., Bono, F., Iamoni, G., Tinelli, C., Mondelli, M., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8698200 · Cited by 179
Kew, M. C., Yu, M.-C., Kedda, M., Coppin, A., Sarkin, A., & Hodkinson, J. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70233-6 · Cited by 169
Benvegnù, L. (1997) · Hepatology · doi:10.1053/jhep.1997.v25.pm0008985292 · Cited by 152
The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.
Bisceglie, A. M. D., Order, S. E., Klein, J., Waggoner, J. G., Sjögren, M. H., Kuo, G. C., Houghton, M., Choo, Q. L., & Hoofnagle, J. H. (1991) · PubMed · Cited by 150
Turlin, B., Juguet, F., Moirand, R., Quilleuc, D. L., Loréal, O., Campion, J. P., Launois, B., Ramée, M.-P., Brissot, P., & Deugnier, Y. (1995) · Hepatology · doi:10.1002/hep.1840220212 · Cited by 129
Porphyria Cutanea Tarda and Hepatocellular Carcinoma
Salata, H., Cortés, J. M. S., de Salamanca, R. E., Oliva, H., Castro, A., Kusak, E., Carréño, V., & Guio, C. H. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80746-7 · Cited by 96
Hadziyannis, S. J., Tabor, E., Kaklamani, E., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600510 · Cited by 85
Tanaka, K., Ikematsu, H., Hirohata, T., & Kashiwagi, S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.11.742 · Cited by 74
Yu, M. C., Yuan, J., Ross, R. K., & Govindarajan, S. (1997) · Hepatology · doi:10.1002/hep.510250141 · Cited by 72
Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma.
Gerber, M. A., Shieh, Y. S., Shim, K.-S., Thung, S. N., Demetris, A. J., Schwartz, M., Akyol, G., & Dash, S. (1992) · PubMed · Cited by 71
Kao, J., Chen, P., My, L., Wy, C., Liu, D., Wang, J., Mc, S., & Chen, D. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70139-2 · Cited by 68
Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma.
Bukh, J., Miller, R. H., Kew, M. C., & Purcell, R. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1848 · Cited by 66
Does hepatitis C virus infection contribute to hepatocellular carcinoma in hong kong?
Leung, N. W. Y., Lai, J.-Z., Tam, J. S. L., Leung, T. W. T., Shiu, W. C. T., Lau, W. Y., & LI, A. K. C. (1992) · Cancer · doi:10.1002/1097-0142(19920701)70:1<40::aid-cncr2820700107>3.0.co;2-p · Cited by 46
Ramesh, R., Munshi, A., & Panda, S. K. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb01006.x · Cited by 31
Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma
Colombo, M., Rumi, M. G., Donato, M. F., et al. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297459 · Cited by 30
Mangia, A., Vallari, D. S., & Bisceglie, A. M. D. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890430205 · Cited by 28
Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia
Karawi, M. A. A., Shariq, S., Mohamed, A. R. E. S., et al. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb00970.x · Cited by 25
Hepatitis C virus infection in cirrhosis and primary hepatocellular carcinoma in Senegal
Coursaget, P., Leboulleux, D., Cann, P. L., Bao, O., & Coll‐Seck, A. M. (1992) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(92)90107-n · Cited by 19
Cited by
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Imamura, H., Matsuyama, Y., Tanaka, E., Ohkubo, T., Hasegawa, K., Miyagawa, S., Sugawara, Y., Minagawa, M., Takayama, T., Kawasaki, S., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00360-4 · Cited by 1,589
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C., & Roudot-Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,341
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Molecular biology of hepatitis B virus infection
Seeger, C., & Mason, W. S. (2015) · Virology · doi:10.1016/j.virol.2015.02.031 · Cited by 866
Metadata
- Authors
- Di Bisceglie, A. M.
- Venue
- Hepatology
- Published
- 1997-12
- Volume
- 26
- Issue
- Supplement 3
- Pages
- 34S-38S
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2064428351
- Cited by
- 558
- References
- 48
- FWCI
- 17.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.